LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 2 analysts with an average price target of $4.4. This is a potential upside of $2.21 (100.91%) from yesterday's end of day stock price of $2.19.

Lexicon Pharmaceuticals's activity chart (see below) currently has 36 price targets and 35 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.14% with an average time for these price targets to be met of 74 days.

Highest price target for LXRX is $4, Lowest price target is $4, average price target is $4.4.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 12-Dec-2023. First documented stock forecast 11-Oct-2013.

Currently out of the existing stock ratings of LXRX, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$1.81 (82.65%)

8

3 months 16 days ago

4/15 (26.67%)

$2.82 (238.98%)

47

Buy

10

$7.81 (356.62%)

10

1 years 5 months 25 days ago

0/2 (0%)

$7.55 (308.16%)

Hold

7

$5.91 (542.20%)

3 years 1 months 28 days ago

3/3 (100%)

$1.33 (13.05%)

55

Buy

2

$-0.19 (-8.68%)

3 years 1 months 28 days ago

2/6 (33.33%)

$-5.91 (-74.72%)

409

Hold

3 years 2 months 13 days ago

1/1 (100%)

$0.8 (36.36%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 74 days on average for the stock forecasts to be realized with a an average price target met ratio 37.14

Which analyst has the current highest performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

Jessica Fye works at JPMORGAN and has 8 price targets and 4 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $7.81

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Liana Moussatos with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?